Zenara introduces first generic of Paxlovid for COVID-19 in India

Paxzen, manufactured at Zenara’s US FDA and EU approved facility in Hyderabad, will be sold at a maximum retail price of Rs 5,200 per box

FPJ BureauUpdated: Monday, September 12, 2022, 03:06 PM IST
article-image
Zenara Pharma has launched the first generic copy of Pfizer’s anti-covid pill, under the brand name Paxzen | ANI

Hyderabad-based drugmaker Zenara Pharma has launched the first generic copy of Pfizer’s anti-covid pill -- nirmatrelvir and ritonavir combination tablet -- in India, under the brand name Paxzen.

The combination pack, as a treatment option for patients with symptoms of Covid-19, had undergone necessary trials in India following the generic licensing of the same by the US drug giant to Zanara and a few other local drug makers.

Paxzen, manufactured at Zenara’s US FDA and EU approved facility in Hyderabad, will be sold at a maximum retail price of Rs 5,200 per box, equivalent to one full course of treatment per patient.

Zenara Pharma, a fully owned subsidiary of Biophore India Pharmaceuticals, is the first company to launch the product in India.

(To receive our E-paper on whatsapp daily, please click here. To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

Indian Oil keeps prices of petrol, diesel unchanged in Delhi since Thursday; check rates in other...

Indian Oil keeps prices of petrol, diesel unchanged in Delhi since Thursday; check rates in other...

Nervousness in global financial markets but Indian economy continues to be resilient: RBI chief...

Nervousness in global financial markets but Indian economy continues to be resilient: RBI chief...

Opening bell: Sensex, Nifty fall in early trade ahead of RBI monetary policy decision

Opening bell: Sensex, Nifty fall in early trade ahead of RBI monetary policy decision

Rupee rises 24 paise to 81.49 against US dollar in early trade

Rupee rises 24 paise to 81.49 against US dollar in early trade

RBI hikes benchmark lending rate by 50 basis points for 4th time in a row to rein in inflation...

RBI hikes benchmark lending rate by 50 basis points for 4th time in a row to rein in inflation...